Sleep
Therapy,
Redefined.

Aims to restore comfortable, restful nights
for patients with sleep apnea

Aims to restore comfortable, restful nights for patients with sleep apnea

ADAPTIVE THERAPY.
PHYSIOLOGIC RESPONSE.

Designed for patients with moderate-to-severe sleep apnea, Lunair is developing an implantable neurostimulation device and connected platform that aims to overcome current treatment limitations and restore healthy sleep.
PHRENIC NERVE STIMULATION
The phrenic nerve activates the diaphragm and communicates with the brainstem to control respiration. Phrenic nerve stimulation has a history of safe use for diverse indications, including sleep apnea.
COORDINATED AIRWAY REFLEX
Phrenic nerve stimulation activates a coordinated upper airway reflex of respiratory muscles to maintain an open airway during sleep.1
RESPIRATION SENSING

Closed-loop system senses respiration and automatically adjusts stimulation to meet the patient’s respiratory needs.

PHRENIC
NERVE
STIMULATION

The phrenic nerve activates the diaphragm and communicates with the brainstem to control respiration. Phrenic nerve stimulation has a history of safe use for diverse indications, including sleep apnea.

COORDINATED
AIRWAY
REFLEX

Phrenic nerve stimulation activates a coordinated upper airway reflex of respiratory muscles to maintain an open airway during sleep.1

RESPIRATION
SENSING

Closed-loop system senses respiration and automatically adjusts stimulation to meet the patient’s respiratory needs.

THE LUNAIR SYSTEM

STIMULATION LEAD

Stimulates the phrenic nerve to activate a natural airway reflex, maintaining stability, without masks, mouthpieces, wearables, or forced tongue movements.

PULSE GENERATOR

Acting as the system’s brain, it adjusts the proprietary stimulation algorithm based on respiration and sleep parameters.

TITRATION LEAD

Monitors the patient’s response to sleep and stimulation, providing valuable information for auto-titration of the system.

Device under investigation.

THE LUNAIR SYSTEM

STIMULATION LEAD

Stimulates the phrenic nerve to activate a natural airway reflex, maintaining stability, without masks, mouthpieces, wearables, or forced tongue movements.

PULSE GENERATOR

Acting as the system’s brain, it adjusts the proprietary stimulation algorithm based on respiration and sleep parameters.

TITRATION LEAD

Monitors the patient’s response to sleep and stimulation, providing valuable information for auto-titration of the system.

Device under investigation.

SIMPLIFIED SLEEP CARE.
FOR EVERYONE.

Designed to optimize the titration process, the Lunair System includes a digital ecosystem to streamline the patient care pathway.
CLINICIAN PORTAL

Supports objective, information-driven patient management based on key sleep metrics.

PATIENT APP

Enables adjustment of key comfort parameters and visibility to sleep metrics to support patient compliance and good sleep habits.

SIMPLIFIED SLEEP CARE. FOR EVERYONE.

Designed to optimize the titration process, the Lunair System includes a digital ecosystem to streamline the patient care pathway.
CLINICIAN PORTAL
Supports objective, information-driven patient management based on key sleep metrics.
PATIENT APP
Enables adjustment of key comfort parameters and visibility to sleep metrics to support patient compliance and good sleep habits.
THE UNMET NEED
IN SLEEP APNEA

Moderate-to-severe sleep apnea affects up to 12% of the US population, with serious impacts on productivity, cardiovascular health, and quality of life.2

Unfortunately, today’s solutions leave many patients seeking alternative therapies.

THE UNMET NEED
IN SLEEP APNEA

Moderate-to-severe sleep apnea affects up to 12% of the US population, with serious impacts on productivity, cardiovascular health, and quality of life.2

Unfortunately, today’s solutions leave many patients seeking alternative therapies.

WE BELIEVE IT IS TIME TO
TREAT MORE PATIENTS. BETTER.

Lunair is dedicated to unlocking effective treatment for patients suffering from sleep apnea.

Mark Christopherson
CEO, Lunair Medical
Michael Hurley, MD
Principal, Deerfield Management
Paul LaViolette
Managing Partner, SV Health Investors
Howard Levin, MD
CEO & CMO, Deerfield Catalyst
David Neustaedter
Venture Partner, Deerfield Management
JOIN THE TEAM
pioneering next-generation
sleep apnea care
  1. Nair J et al. Anatomy and physiology of phrenic afferent neurons. J Neurophysiol. 2017 Dec 1;118(6):2975-2990.
  2. A Hidden Health Crisis Costing America Billions. American Academy of Sleep Apnea (AASA) and Frost & Sullivan. 2016.